A new horizon in pathway biomarkers

The key to precision medicine

Molecular phenotypes are accurately defined as TopMD Maps of activated gene pathways; robust pathway biomarkers for increased efficiency of drug development and patient treatment.

>

What does personalised medicine mean for you?

Technology is making it possible to tailor treatments to ever smaller groups of patients.

>> Learn More
>

TopMD fights COVID-19

TopMD leads molecular phenotyping in DRAGON, the £14M EU-funded international consortium for COVID-19 advanced diagnostics.

>> Learn More
>

Personalized Medicine

NIH research is working hard to solve the puzzle of how genes and lifestyle connect to affect our lives and our health.

>> Learn More